Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Invested Capital (2021 - 2025)

PAVmed has reported Invested Capital over the past 5 years, most recently at $33.4 million for Q4 2025.

  • Quarterly results put Invested Capital at $33.4 million for Q4 2025, up 25.54% from a year ago — trailing twelve months through Dec 2025 was $33.4 million (up 25.54% YoY), and the annual figure for FY2025 was $33.4 million, up 25.54%.
  • Invested Capital for Q4 2025 was $33.4 million at PAVmed, down from $39.4 million in the prior quarter.
  • Over the last five years, Invested Capital for PAVM hit a ceiling of $79.4 million in Q4 2021 and a floor of -$570000.0 in Q2 2023.
  • Median Invested Capital over the past 5 years was $37.3 million (2021), compared with a mean of $40.1 million.
  • Biggest five-year swings in Invested Capital: tumbled 100.8% in 2023 and later surged 4548.77% in 2024.
  • PAVmed's Invested Capital stood at $79.4 million in 2021, then tumbled by 43.86% to $44.6 million in 2022, then plummeted by 54.73% to $20.2 million in 2023, then soared by 31.83% to $26.6 million in 2024, then grew by 25.54% to $33.4 million in 2025.
  • The last three reported values for Invested Capital were $33.4 million (Q4 2025), $39.4 million (Q3 2025), and $35.0 million (Q2 2025) per Business Quant data.